Skip to content

Characterization of Corticospinal Excitability During Progressive Skin Cooling

Characterization of Corticospinal Excitability During Progressive Skin Cooling

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04253730
Enrollment
10
Registered
2020-02-05
Start date
2019-08-22
Completion date
2022-06-01
Last updated
2022-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypothermia Due to Cold Environment

Keywords

Body Temperature, Skin Temperature, Cooling

Brief summary

This study characterizes the changes in corticospinal excitability that accompany basic cold stress via skin cooling that result in reduced skin or core temperature and shivering.

Detailed description

Cold stress is known to impair both fine and gross motor movement. Reductions in performance may have life threatening consequences in survival situations where maintenance of muscle control is necessary. Much of the effects cooling has on muscle performance is directly due to its effects on muscle tissue itself, whereas less is known about the effects on the central nervous system. Therefore, the purpose of the study was to characterize corticospinal excitability that accompanies basic cold stress via progressive skin cooling, resulting in reductions in skin (Tsk) or core (Tco) temperature and shivering.

Interventions

60-90 mins of cooling via a liquid perfused suit circulating \ 4-10°C liquid.

Sponsors

University of Manitoba
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Intervention model description

Repeat Measures

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy adult * Right Handed * Pass Magnetic Stimulation Safety Checklist * Pass Medical Screening Questionnaire

Exclusion criteria

* Left Handed * Any adverse responses to cold exposure (Raynaud's Syndrome) * Cardiorespiratory Disease

Design outcomes

Primary

MeasureTime frameDescription
Change in Corticospinal Excitabilityat 0, 20, 40, 60 and 90 minutesMotor Evoked Potentials (MEP) as a percentage of the maximal compound muscle action potential (Mmax) measured via MEG at the Biceps Brachii will serve as the indices of Corticospinal excitbaility

Secondary

MeasureTime frameDescription
Change in Skin Temperatureat 0, 20, 40, 60 and 90 minutesMean skin temperature of 7 sites
Change in Core Temperatureat 0, 20, 40, 60 and 90 minutesEsophageal temperature is the most accurate method representing the temperature of the heart.
Change in Spinal Excitabilityat 0, 20, 40, 60 and 90 minutesCervicomedullary Motor Evoked Potentials (CMEP) as a percentage of the maximal compound muscle action potential (Mmax) measured via MEG at the Biceps Brachii will serve as the indices of spinal excitability
Change in Metabolic Heat Productionat 0, 20, 40, 60 and 90 minutesMetabolic heat production serves as an objective way to quantify shivering thermogenesis.

Other

MeasureTime frameDescription
Change in Peripheral nerve excitabilityat 0, 20, 40, 60 and 90 minutesExcitability of the peripheral nerve measured via EMG at the biceps brachia ( the maximal compound motor action potential (Mmax).
Change in Maximal Voluntary Contraction of Elbow Flexorsat 0, 20, 40, 60 and 90 minutesMaximal Isometric Force of elbow flexors measured in kg of force

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026